Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy

por Kopka, Klaus
Publicado 2014

Lutathera(®): The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy

por Hennrich, Ute, Kopka, Klaus
Publicado 2019

Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis

por Krutzek, Fabian, Kopka, Klaus, Stadlbauer, Sven
Publicado 2022

Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangement

por Matthias, Jessica, Kanagasundaram, Thines, Kopka, Klaus, Kramer, Carsten S
Publicado 2019

A new approach to silicon rhodamines by Suzuki–Miyaura coupling – scope and limitations

por Kanagasundaram, Thines, Timmermann, Antje, Kramer, Carsten S, Kopka, Klaus
Publicado 2019

Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [(18)F]PSMA-1007, a PET T...

por Katzschmann, Ines, Marx, Heike, Kopka, Klaus, Hennrich, Ute
Publicado 2021

Efforts toward PET-Activatable Red-Shifted Silicon Rhodamines and Silicon Pyronine Dyes

por Kramer, Carsten Sven, Kanagasundaram, Thines, Matthias, Jessica, Kopka, Klaus
Publicado 2023

Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases

por Breyholz, Hans-Jörg, Kopka, Klaus, Schäfers, Michael, Wagner, Stefan
Publicado 2017

Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination

por Kramer, Carsten Sven, Greiner, Luca, Kopka, Klaus, Schäfer, Martin
Publicado 2022

Radiolabeled PSMA Inhibitors

por Neels, Oliver C., Kopka, Klaus, Liolios, Christos, Afshar-Oromieh, Ali
Publicado 2021

Synthesis of [(18)F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective

por Kniess, Torsten, Zessin, Jörg, Mäding, Peter, Kuchar, Manuela, Kiss, Oliver, Kopka, Klaus
Publicado 2023

Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov

por Zippel, Claus, Ronski, Sarah C., Bohnet-Joschko, Sabine, Giesel, Frederik L., Kopka, Klaus
Publicado 2020

Sub‐10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy

por Reissig, Falco, Zarschler, Kristof, Hübner, René, Pietzsch, Hans‐Jürgen, Kopka, Klaus, Mamat, Constantin
Publicado 2020

Live-cell imaging with Aspergillus fumigatus-specific fluorescent siderophore conjugates

por Pfister, Joachim, Lichius, Alexander, Summer, Dominik, Haas, Hubertus, Kanagasundaram, Thines, Kopka, Klaus, Decristoforo, Clemens
Publicado 2020

(68)Ga, (44)Sc and (177)Lu-labeled AAZTA(5)-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues

por Sinnes, Jean-Philippe, Bauder-Wüst, Ulrike, Schäfer, Martin, Moon, Euy Sung, Kopka, Klaus, Rösch, Frank
Publicado 2020

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents

por Kanagasundaram, Thines, Laube, Markus, Wodtke, Johanna, Kramer, Carsten Sven, Stadlbauer, Sven, Pietzsch, Jens, Kopka, Klaus
Publicado 2021

Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives

por Kubeil, Manja, Martínez, Irma Ivette Santana, Bachmann, Michael, Kopka, Klaus, Tuck, Kellie L., Stephan, Holger
Publicado 2022

Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas

por Glowa, Christin, Peschke, Peter, Brons, Stephan, Neels, Oliver C., Kopka, Klaus, Debus, Jürgen, Karger, Christian P.
Publicado 2017

Efficient Production of the PET Radionuclide (133)La for Theranostic Purposes in Targeted Alpha Therapy Using the (134)Ba(p,2n)(133)La Reaction

por Brühlmann, Santiago Andrés, Kreller, Martin, Pietzsch, Hans-Jürgen, Kopka, Klaus, Mamat, Constantin, Walther, Martin, Reissig, Falco
Publicado 2022

Cyclotron-Based Production of (67)Cu for Radionuclide Theranostics via the (70)Zn(p,α)(67)Cu Reaction

por Brühlmann, Santiago Andrés, Walther, Martin, Kreller, Martin, Reissig, Falco, Pietzsch, Hans-Jürgen, Kniess, Torsten, Kopka, Klaus
Publicado 2023